1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Tomizawa, T. Koshiba, S. Inoue, M. Kigawa, T. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structure of the 19th filamin domain from human Filamin-B 10.2210/pdb2di8/pdb pdb_00002di8 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11537.700 Filamin-B Filamin domain 1 man polymer FLN-B, Beta-filamin, Actin-binding-like protein, Thyroid autoantigen, Truncated actin-binding protein, Truncated ABP, ABP-280 homolog, ABP-278, Filamin 3, Filamin homolog 1, Fh1 no no GSSGSSGIGDARRAKVYGRGLSEGRTFEMSDFIVDTRDAGYGGISLAVEGPSKVDIQTEDLEDGTCKVSYFPTVPGVYIV STKFADEHVPGSPFTVKISGEGRVKSGPSSG GSSGSSGIGDARRAKVYGRGLSEGRTFEMSDFIVDTRDAGYGGISLAVEGPSKVDIQTEDLEDGTCKVSYFPTVPGVYIV STKFADEHVPGSPFTVKISGEGRVKSGPSSG A hsk003002600.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis FLNB 9606 Homo sapiens Cell free synthesis PLASMID P050919-18 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-09-29 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Y PDBJ Y PDBJ 2006-03-29 REL REL target function, structures with the lowest energy, structures with the least restraint violations 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 296 K torsion angle dynamics, restrainted molecular dynamics 1 lowest energy 0.80mM Filamin domain U-15N,13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 3.5 Delaglio, F. processing NMRPipe 20030801 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.9742 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 800 Bruker AVANCE GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A ILE 8 n 8 ILE 8 A GLY 9 n 9 GLY 9 A ASP 10 n 10 ASP 10 A ALA 11 n 11 ALA 11 A ARG 12 n 12 ARG 12 A ARG 13 n 13 ARG 13 A ALA 14 n 14 ALA 14 A LYS 15 n 15 LYS 15 A VAL 16 n 16 VAL 16 A TYR 17 n 17 TYR 17 A GLY 18 n 18 GLY 18 A ARG 19 n 19 ARG 19 A GLY 20 n 20 GLY 20 A LEU 21 n 21 LEU 21 A SER 22 n 22 SER 22 A GLU 23 n 23 GLU 23 A GLY 24 n 24 GLY 24 A ARG 25 n 25 ARG 25 A THR 26 n 26 THR 26 A PHE 27 n 27 PHE 27 A GLU 28 n 28 GLU 28 A MET 29 n 29 MET 29 A SER 30 n 30 SER 30 A ASP 31 n 31 ASP 31 A PHE 32 n 32 PHE 32 A ILE 33 n 33 ILE 33 A VAL 34 n 34 VAL 34 A ASP 35 n 35 ASP 35 A THR 36 n 36 THR 36 A ARG 37 n 37 ARG 37 A ASP 38 n 38 ASP 38 A ALA 39 n 39 ALA 39 A GLY 40 n 40 GLY 40 A TYR 41 n 41 TYR 41 A GLY 42 n 42 GLY 42 A GLY 43 n 43 GLY 43 A ILE 44 n 44 ILE 44 A SER 45 n 45 SER 45 A LEU 46 n 46 LEU 46 A ALA 47 n 47 ALA 47 A VAL 48 n 48 VAL 48 A GLU 49 n 49 GLU 49 A GLY 50 n 50 GLY 50 A PRO 51 n 51 PRO 51 A SER 52 n 52 SER 52 A LYS 53 n 53 LYS 53 A VAL 54 n 54 VAL 54 A ASP 55 n 55 ASP 55 A ILE 56 n 56 ILE 56 A GLN 57 n 57 GLN 57 A THR 58 n 58 THR 58 A GLU 59 n 59 GLU 59 A ASP 60 n 60 ASP 60 A LEU 61 n 61 LEU 61 A GLU 62 n 62 GLU 62 A ASP 63 n 63 ASP 63 A GLY 64 n 64 GLY 64 A THR 65 n 65 THR 65 A CYS 66 n 66 CYS 66 A LYS 67 n 67 LYS 67 A VAL 68 n 68 VAL 68 A SER 69 n 69 SER 69 A TYR 70 n 70 TYR 70 A PHE 71 n 71 PHE 71 A PRO 72 n 72 PRO 72 A THR 73 n 73 THR 73 A VAL 74 n 74 VAL 74 A PRO 75 n 75 PRO 75 A GLY 76 n 76 GLY 76 A VAL 77 n 77 VAL 77 A TYR 78 n 78 TYR 78 A ILE 79 n 79 ILE 79 A VAL 80 n 80 VAL 80 A SER 81 n 81 SER 81 A THR 82 n 82 THR 82 A LYS 83 n 83 LYS 83 A PHE 84 n 84 PHE 84 A ALA 85 n 85 ALA 85 A ASP 86 n 86 ASP 86 A GLU 87 n 87 GLU 87 A HIS 88 n 88 HIS 88 A VAL 89 n 89 VAL 89 A PRO 90 n 90 PRO 90 A GLY 91 n 91 GLY 91 A SER 92 n 92 SER 92 A PRO 93 n 93 PRO 93 A PHE 94 n 94 PHE 94 A THR 95 n 95 THR 95 A VAL 96 n 96 VAL 96 A LYS 97 n 97 LYS 97 A ILE 98 n 98 ILE 98 A SER 99 n 99 SER 99 A GLY 100 n 100 GLY 100 A GLU 101 n 101 GLU 101 A GLY 102 n 102 GLY 102 A ARG 103 n 103 ARG 103 A VAL 104 n 104 VAL 104 A LYS 105 n 105 LYS 105 A SER 106 n 106 SER 106 A GLY 107 n 107 GLY 107 A PRO 108 n 108 PRO 108 A SER 109 n 109 SER 109 A SER 110 n 110 SER 110 A GLY 111 n 111 GLY 111 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 17 A N TYR 17 A O ILE 33 A O ILE 33 A N SER 30 A N SER 30 A O TYR 70 A O TYR 70 A O SER 69 A O SER 69 A N GLN 57 A N GLN 57 A N GLY 24 A N GLY 24 A O SER 99 A O SER 99 A O PHE 94 A O PHE 94 A N VAL 80 A N VAL 80 A O SER 81 A O SER 81 A N ALA 47 A N ALA 47 1 A SER 5 -38.86 147.39 1 A VAL 89 -48.30 156.88 1 A PRO 90 -69.77 83.29 1 A GLU 101 -54.53 173.84 1 A ARG 103 -42.53 153.42 2 A SER 3 -41.54 108.55 2 A SER 52 -170.02 138.90 2 A PRO 90 -69.78 81.12 3 A ALA 85 71.99 45.84 3 A VAL 89 -47.20 156.55 3 A PRO 90 -69.76 81.85 3 A SER 106 -40.42 108.16 4 A SER 22 -97.00 -64.54 4 A VAL 89 -47.73 156.58 4 A PRO 90 -69.79 83.00 4 A GLU 101 -172.38 113.87 4 A VAL 104 -57.60 109.41 4 A LYS 105 -35.17 127.22 4 A SER 109 34.79 45.75 5 A PRO 51 -69.76 1.79 5 A VAL 89 -48.03 157.18 5 A PRO 90 -69.75 82.97 5 A GLU 101 -35.83 143.11 6 A SER 2 -37.48 106.78 6 A SER 22 -104.51 -66.42 6 A VAL 89 -47.43 157.27 6 A PRO 90 -69.80 80.57 6 A PRO 108 -69.77 90.83 7 A ALA 47 -166.77 118.89 7 A VAL 89 -49.28 157.25 7 A PRO 90 -69.75 83.84 7 A VAL 104 -42.15 152.66 8 A SER 5 -123.39 -55.15 8 A SER 6 -38.81 157.44 8 A SER 22 -101.93 -62.44 8 A PRO 51 -69.79 1.39 8 A VAL 89 -45.41 156.50 8 A PRO 90 -69.75 79.93 8 A VAL 104 -44.19 105.99 8 A SER 110 70.55 42.12 9 A SER 22 -110.08 -73.57 9 A PRO 90 -69.79 85.94 10 A PRO 51 -69.71 1.28 10 A VAL 89 -46.22 156.09 10 A PRO 90 -69.77 84.57 10 A GLU 101 -37.45 94.95 10 A ARG 103 -49.47 106.64 11 A SER 3 -64.87 80.03 11 A SER 22 -108.53 -61.10 11 A VAL 89 -45.93 156.40 11 A PRO 90 -69.75 80.29 11 A SER 99 -72.70 -71.78 11 A VAL 104 -45.51 151.16 11 A SER 106 -91.42 -64.90 12 A SER 22 -94.57 -69.46 12 A GLU 87 -160.03 114.96 12 A PRO 90 -69.77 87.16 12 A ARG 103 -170.37 111.02 12 A VAL 104 -46.20 155.53 12 A SER 109 -36.62 120.45 12 A SER 110 -64.61 95.31 13 A SER 6 -100.96 55.49 13 A SER 22 -94.70 -63.79 13 A PHE 27 45.47 29.58 13 A VAL 89 -46.71 156.32 13 A PRO 90 -69.76 86.38 13 A GLU 101 -57.17 89.88 13 A SER 109 -37.79 111.99 14 A ALA 47 -164.58 108.18 14 A ASP 55 -49.61 152.38 14 A VAL 89 -44.99 155.80 14 A PRO 90 -69.81 86.30 14 A ARG 103 -43.93 168.00 14 A VAL 104 -44.48 101.66 14 A SER 106 -69.14 81.14 14 A SER 109 -129.46 -56.86 14 A SER 110 -69.62 98.44 15 A SER 22 -103.34 -62.37 15 A MET 29 -55.82 109.73 15 A ALA 47 -160.18 111.55 15 A ALA 85 70.03 43.29 15 A VAL 89 -47.43 156.18 15 A PRO 90 -69.73 85.24 15 A SER 99 -57.67 -72.43 15 A LYS 105 -41.14 160.25 16 A SER 5 -57.12 171.52 16 A SER 22 -99.73 -60.77 16 A PRO 51 -69.85 1.86 16 A THR 73 -130.85 -42.36 16 A VAL 89 -44.24 156.03 16 A PRO 90 -69.79 88.59 16 A PRO 93 -69.75 -179.33 16 A GLU 101 -129.30 -55.54 16 A PRO 108 -69.79 2.83 17 A ALA 47 -161.47 118.69 17 A VAL 89 -46.24 156.26 17 A PRO 90 -69.74 82.82 17 A ARG 103 -162.67 106.71 17 A SER 106 -168.46 111.54 17 A PRO 108 -69.79 2.73 18 A SER 5 -42.85 164.82 18 A SER 6 39.59 51.59 18 A SER 22 -100.25 -66.84 18 A VAL 89 -45.31 155.99 18 A PRO 90 -69.74 85.06 18 A VAL 104 -44.37 151.29 19 A VAL 89 -46.76 156.23 19 A PRO 90 -69.82 89.13 19 A GLU 101 -114.27 57.60 20 A SER 6 -44.07 164.16 20 A ALA 47 -162.12 108.38 20 A ASP 55 -49.44 152.38 20 A VAL 89 -44.44 156.00 20 A PRO 90 -69.77 87.86 20 A GLU 101 -37.28 107.16 20 A ARG 103 -36.34 123.79 20 A VAL 104 -46.22 151.86 Solution structure of the 19th filamin domain from human Filamin-B 1 N N A ASP 10 A ASP 10 HELX_P A ALA 14 A ALA 14 5 1 5 STRUCTURAL PROTEIN beta-sandwich, immunoglobulin-like fold, filamin domain, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, STRUCTURAL PROTEIN A SER 92 A SER 92 1 A PRO 93 A PRO 93 -0.11 A SER 92 A SER 92 2 A PRO 93 A PRO 93 0.00 A SER 92 A SER 92 3 A PRO 93 A PRO 93 -0.08 A SER 92 A SER 92 4 A PRO 93 A PRO 93 0.08 A SER 92 A SER 92 5 A PRO 93 A PRO 93 0.02 A SER 92 A SER 92 6 A PRO 93 A PRO 93 0.00 A SER 92 A SER 92 7 A PRO 93 A PRO 93 -0.06 A SER 92 A SER 92 8 A PRO 93 A PRO 93 -0.12 A SER 92 A SER 92 9 A PRO 93 A PRO 93 -0.10 A SER 92 A SER 92 10 A PRO 93 A PRO 93 -0.05 A SER 92 A SER 92 11 A PRO 93 A PRO 93 -0.08 A SER 92 A SER 92 12 A PRO 93 A PRO 93 0.03 A SER 92 A SER 92 13 A PRO 93 A PRO 93 -0.05 A SER 92 A SER 92 14 A PRO 93 A PRO 93 -0.09 A SER 92 A SER 92 15 A PRO 93 A PRO 93 0.01 A SER 92 A SER 92 16 A PRO 93 A PRO 93 -0.09 A SER 92 A SER 92 17 A PRO 93 A PRO 93 -0.04 A SER 92 A SER 92 18 A PRO 93 A PRO 93 0.04 A SER 92 A SER 92 19 A PRO 93 A PRO 93 -0.08 A SER 92 A SER 92 20 A PRO 93 A PRO 93 -0.01 FLNB_HUMAN UNP 1 1999 O75369 1999 2096 2DI8 8 105 O75369 A 1 8 105 1 cloning artifact GLY 1 2DI8 A O75369 UNP 1 1 cloning artifact SER 2 2DI8 A O75369 UNP 2 1 cloning artifact SER 3 2DI8 A O75369 UNP 3 1 cloning artifact GLY 4 2DI8 A O75369 UNP 4 1 cloning artifact SER 5 2DI8 A O75369 UNP 5 1 cloning artifact SER 6 2DI8 A O75369 UNP 6 1 cloning artifact GLY 7 2DI8 A O75369 UNP 7 1 cloning artifact SER 106 2DI8 A O75369 UNP 106 1 cloning artifact GLY 107 2DI8 A O75369 UNP 107 1 cloning artifact PRO 108 2DI8 A O75369 UNP 108 1 cloning artifact SER 109 2DI8 A O75369 UNP 109 1 cloning artifact SER 110 2DI8 A O75369 UNP 110 1 cloning artifact GLY 111 2DI8 A O75369 UNP 111 4 4 anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel A LYS 15 A LYS 15 A GLY 18 A GLY 18 A SER 30 A SER 30 A ASP 35 A ASP 35 A CYS 66 A CYS 66 A TYR 70 A TYR 70 A ILE 56 A ILE 56 A GLN 57 A GLN 57 A GLU 23 A GLU 23 A ARG 25 A ARG 25 A PHE 94 A PHE 94 A SER 99 A SER 99 A VAL 77 A VAL 77 A PHE 84 A PHE 84 A ILE 44 A ILE 44 A GLU 49 A GLU 49